This inventor holds 2 USPTO granted patents. Top assignees: Gent Universiteit, University of Ghent. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2011
Title: Wim Vanden Berghe: Innovator in Anti-Inflammatory Agents
Introduction
Wim Vanden Berghe is a notable inventor based in Gentbrugge, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of 2 patents, his work has the potential to impact the treatment of various inflammatory diseases.
Latest Patents
Vanden Berghe's latest patents include innovative compounds that serve as anti-inflammatory agents. One of his inventions focuses on synephrine derivatives, which are designed to provide therapeutic benefits in managing inflammation. Another significant patent involves the use of specific carboxy compounds, particularly 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride, in treating inflammatory diseases. This invention also encompasses a pharmaceutical composition that includes this active ingredient along with acceptable excipients.
Career Highlights
Throughout his career, Wim Vanden Berghe has been associated with esteemed institutions such as Universiteit Gent and Gent Universiteit. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Karolien De Bosscher and Guy Haegeman. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Wim Vanden Berghe's contributions to the field of anti-inflammatory agents highlight his role as an influential inventor. His patents and collaborations reflect a commitment to improving healthcare through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile